165 related articles for article (PubMed ID: 35772016)
1. Malassezia species: the need to establish epidemiological cutoff values.
Rojas FD; Sosa MLÁ; Latorre W; Mussin J; Alegre L; Giusiano G
Med Mycol; 2022 Aug; 60(8):. PubMed ID: 35772016
[TBL] [Abstract][Full Text] [Related]
2. Antifungal susceptibility of Malassezia furfur, Malassezia sympodialis, and Malassezia globosa to azole drugs and amphotericin B evaluated using a broth microdilution method.
Rojas FD; Sosa Mde L; Fernández MS; Cattana ME; Córdoba SB; Giusiano GE
Med Mycol; 2014 Aug; 52(6):641-6. PubMed ID: 24965946
[TBL] [Abstract][Full Text] [Related]
3. In vitro activity of two amphotericin B formulations against Malassezia furfur strains recovered from patients with bloodstream infections.
Iatta R; Immediato D; Montagna MT; Otranto D; Cafarchia C
Med Mycol; 2015 Apr; 53(3):269-74. PubMed ID: 25631480
[TBL] [Abstract][Full Text] [Related]
4. Comparative evaluation of E-test and CLSI methods for Itraconazole, Fluconazole and Ketoconazole susceptibilities of Microsporum canis strains.
Aneke CI; Rhimi W; Otranto D; Cafarchia C
Mycopathologia; 2020 Jun; 185(3):495-502. PubMed ID: 32468154
[TBL] [Abstract][Full Text] [Related]
5. [Antifungal susceptibility profiles of Candida species to triazole: application of new CLSI species-specific clinical breakpoints and epidemiological cutoff values for characterization of antifungal resistance].
Karabıçak N; Alem N
Mikrobiyol Bul; 2016 Jan; 50(1):122-32. PubMed ID: 27058336
[TBL] [Abstract][Full Text] [Related]
6. A proposal for antifungal epidemiological cut-off values against Histoplasma capsulatum var. capsulatum based on the susceptibility of isolates from HIV-infected patients with disseminated histoplasmosis in Northeast Brazil.
Brilhante RSN; Guedes GMM; Silva MLQD; Castelo-Branco DSCM; Cordeiro RA; Sidrim JJC; Rocha MFG
Int J Antimicrob Agents; 2018 Aug; 52(2):272-277. PubMed ID: 29592837
[TBL] [Abstract][Full Text] [Related]
7. Azole susceptibility of Malassezia pachydermatis and Malassezia furfur and tentative epidemiological cut-off values.
Cafarchia C; Iatta R; Immediato D; Puttilli MR; Otranto D
Med Mycol; 2015 Sep; 53(7):743-8. PubMed ID: 26162472
[TBL] [Abstract][Full Text] [Related]
8. [In vitro antifungal activity of azoles and amphotericin B against Malassezia furfur by the CLSI M27-A3 microdilution and Etest
Galvis-Marín JC; Rodríguez-Bocanegra MX; Pulido-Villamarín ADP; Castañeda-Salazar R; Celis-Ramírez AM; Linares-Linares MY
Rev Iberoam Micol; 2017; 34(2):89-93. PubMed ID: 28214276
[TBL] [Abstract][Full Text] [Related]
9. Antifungal activities of azole agents against the Malassezia species.
Miranda KC; de Araujo CR; Costa CR; Passos XS; de Fátima Lisboa Fernandes O; do Rosário Rodrigues Silva M
Int J Antimicrob Agents; 2007 Mar; 29(3):281-4. PubMed ID: 17223320
[TBL] [Abstract][Full Text] [Related]
10. In vitro sensitivity of Malassezia furfur isolates from HIV-positive and negative patients to antifungal agents.
Ehemann K; Contreras A; Celis-Ramírez AM
Biomedica; 2023 Aug; 43(Sp. 1):120-131. PubMed ID: 37721914
[TBL] [Abstract][Full Text] [Related]
11. In vitro antifungal susceptibility of Malassezia pachydermatis from dogs with and without skin lesions.
Cafarchia C; Figueredo LA; Iatta R; Montagna MT; Otranto D
Vet Microbiol; 2012 Mar; 155(2-4):395-8. PubMed ID: 21962411
[TBL] [Abstract][Full Text] [Related]
12. In vitro susceptibility of fluconazole-susceptible and -resistant isolates of Malassezia pachydermatis against azoles.
Jesus FP; Lautert C; Zanette RA; Mahl DL; Azevedo MI; Machado ML; Dutra V; Botton SA; Alves SH; Santurio JM
Vet Microbiol; 2011 Aug; 152(1-2):161-4. PubMed ID: 21658868
[TBL] [Abstract][Full Text] [Related]
13. In vitro susceptibilities of Aspergillus species to voriconazole, itraconazole, and amphotericin B.
Abraham OC; Manavathu EK; Cutright JL; Chandrasekar PH
Diagn Microbiol Infect Dis; 1999 Jan; 33(1):7-11. PubMed ID: 9990469
[TBL] [Abstract][Full Text] [Related]
14. Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Dannaoui E; Garcia-Effron G; Guinea J; Kidd S; Pelaez T; Sanguinetti M; Meletiadis J; Botterel F; Bustamante B; Chen YC; Chakrabarti A; Chowdhary A; Chryssanthou E; Córdoba S; Gonzalez GM; Guarro J; Johnson EM; Kus JV; Lass-Flörl C; Linares-Sicilia MJ; Martín-Mazuelos E; Negri CE; Pfaller MA; Tortorano AM
Antimicrob Agents Chemother; 2018 Apr; 62(4):. PubMed ID: 29437624
[TBL] [Abstract][Full Text] [Related]
15. Wild-type MIC distributions and epidemiological cutoff values for amphotericin B, flucytosine, and itraconazole and Candida spp. as determined by CLSI broth microdilution.
Pfaller MA; Espinel-Ingroff A; Canton E; Castanheira M; Cuenca-Estrella M; Diekema DJ; Fothergill A; Fuller J; Ghannoum M; Jones RN; Lockhart SR; Martin-Mazuelos E; Melhem MS; Ostrosky-Zeichner L; Pappas P; Pelaez T; Peman J; Rex J; Szeszs MW
J Clin Microbiol; 2012 Jun; 50(6):2040-6. PubMed ID: 22461672
[TBL] [Abstract][Full Text] [Related]
16. Wild-type MIC distributions and epidemiologic cutoff values for fluconazole, posaconazole, and voriconazole when testing Cryptococcus neoformans as determined by the CLSI broth microdilution method.
Pfaller MA; Castanheira M; Diekema DJ; Messer SA; Jones RN
Diagn Microbiol Infect Dis; 2011 Nov; 71(3):252-9. PubMed ID: 21917395
[TBL] [Abstract][Full Text] [Related]
17. Multicenter, International Study of MIC/MEC Distributions for Definition of Epidemiological Cutoff Values for Sporothrix Species Identified by Molecular Methods.
Espinel-Ingroff A; Abreu DPB; Almeida-Paes R; Brilhante RSN; Chakrabarti A; Chowdhary A; Hagen F; Córdoba S; Gonzalez GM; Govender NP; Guarro J; Johnson EM; Kidd SE; Pereira SA; Rodrigues AM; Rozental S; Szeszs MW; Ballesté Alaniz R; Bonifaz A; Bonfietti LX; Borba-Santos LP; Capilla J; Colombo AL; Dolande M; Isla MG; Melhem MSC; Mesa-Arango AC; Oliveira MME; Panizo MM; Pires de Camargo Z; Zancope-Oliveira RM; Meis JF; Turnidge J
Antimicrob Agents Chemother; 2017 Oct; 61(10):. PubMed ID: 28739796
[TBL] [Abstract][Full Text] [Related]
18. Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in
Espinel-Ingroff A; Turnidge J; Alastruey-Izquierdo A; Botterel F; Canton E; Castro C; Chen YC; Chen Y; Chryssanthou E; Dannaoui E; Garcia-Effron G; Gonzalez GM; Govender NP; Guinea J; Kidd S; Lackner M; Lass-Flörl C; Linares-Sicilia MJ; López-Soria L; Magobo R; Pelaez T; Quindós G; Rodriguez-Iglesia MA; Ruiz MA; Sánchez-Reus F; Sanguinetti M; Shields R; Szweda P; Tortorano A; Wengenack NL; Bramati S; Cavanna C; DeLuca C; Gelmi M; Grancini A; Lombardi G; Meletiadis J; Negri CE; Passera M; Peman J; Prigitano A; Sala E; Tejada M
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30323038
[TBL] [Abstract][Full Text] [Related]
19. In vitro antifungal susceptibility of Malassezia furfur from bloodstream infections.
Iatta R; Figueredo LA; Montagna MT; Otranto D; Cafarchia C
J Med Microbiol; 2014 Nov; 63(Pt 11):1467-1473. PubMed ID: 25168965
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility profile and epidemiological cut-off values of Cryptococcus neoformans species complex from Argentina.
Córdoba S; Isla MG; Szusz W; Vivot W; Altamirano R; Davel G
Mycoses; 2016 Jun; 59(6):351-6. PubMed ID: 26865081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]